Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 1257-1263, February 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brockhausen, I.
Right arrow Articles by Baker, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brockhausen, I.
Right arrow Articles by Baker, M. A.

Biosynthesis of O-Glycans in Leukocytes from Normal Donors and from Patients with Leukemia: Increase in O-Glycan Core 2 UDP-GlcNAc:Galß3GalNAc{alpha}-R (GlcNAc to GalNAc) ß(1–6)-N-Acetylglucosaminyltransferase in Leukemic Cells1

I. Brockhausen2, W. Kuhns3, H. Schachter, K. L. Matta, D. R. Sutherland and M. A. Baker

Research Institute, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada [I. B., W. K., H. S.]; Department of Gynecologic Oncology, Roswell Park Memorial Institute, Buffalo, New York 14263 [K. L. M.]; Department of Medicine, Toronto General Hospital and University of Toronto, Toronto, Ontario M5G 1L7, Canada [D. R. S., M. A. B.]; and Department of Pathology, University of North Carolina, School of Medicine, Chapel Hill, North Carolina 27514 [W. K.]

We have studied the biosynthesis of altered O-glycan structures on leukocytes from patients with chronic myelogenous leukemia and with acute myeloblastic leukemia (AML). It has been shown previously that the activity of CMP-NeuAc:Galß1-3GalNAc{alpha}-R (sialic acid to galactose) {alpha}(2–3)-sialyltransferase (EC 2.4.99.4) is increased in leukocytes from patients with chronic myelogenous leukemia (M. A. Baker, A. Kanani, I. Brockhausen, H. Schachter, A. Hindenburg, and R. N. Taub, Cancer Res., 47: 2763–2766, 1987) and with AML (A. Kanani, D. R. Sutherland, E. Fibach, K. L. Matta, A. Hindenburg, I. Brockhausen, W. Kuhns, R. N. Taub, D. van den Eijnden and M. A. Baker, Cancer Res., 50: 5003–5007, 1990). This increased activity may in part be responsible for the hypersialylation observed in leukemic leukocytes; however, hypersialylation may also be due to changes in underlying O-glycan structures. To test this hypothesis, we have assayed in normal human granulocytes and leukemic leukocytes several glycosyltransferases involved in the synthesis and elongation of the four common O-glycan cores. UDP-GlcNAc:Galß1-3GalNAc-R (GlcNAc to GalNAc) ß(1–6)-GlcNAc transferase (EC 2.4.1.102), which synthesizes O-glycan core 2 (GlcNAcß1-6[Galß1-3]GalNAc{alpha}), is significantly elevated in chronic myelogenous leukemia (4-fold) and AML (18-fold) leukocytes relative to normal human granulocytes. Neither normal nor leukemic cells show detectable activities of GlcNAc transferases which synthesize O-glycan core 3 (GlcNAcß1-3GalNAc-R) and core 4 (GlcNAcß1-6[GlcNAcß1-3] GalNAc-R) or the blood group I structure. The ß3-GlcNAc transferase which elongates core 1 and core 2 was found at low levels in normal granulocytes but was not detectable in leukemic cells. The ß3-GlcNAc transferase and ß4-Gal transferase involved in poly-N-acetyllactosamine synthesis, as well as the ß3-Gal transferase synthesizing core 1 (Galß3 GalNAc), were present in all samples but were significantly increased in patients with AML. The observed changes are consistent with hypersialylation in leukemia.

1 This research was supported by a grant from the Canadian Cystic Fibrosis Foundation (H. S.) and by grants from the National Cancer Institute of Canada and the Medical Research Council of Canada (M. A. B. and D. R. S.).

2 To whom requests for reprints should be addressed, at Research Institute, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada.

3 On leave from the University of North Carolina.

Received 9/ 4/90. Accepted 11/29/90.




This article has been cited by other articles:


Home page
GlycobiologyHome page
S. Hagisawa, C. Ohyama, T. Takahashi, M. Endoh, T. Moriya, J. Nakayama, Y. Arai, and M. Fukuda
Expression of core 2 {beta}1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression
Glycobiology, October 1, 2005; 15(10): 1016 - 1024.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
N. Markine-Goriaynoff, L. Gillet, O. A. Karlsen, L. Haarr, F. Minner, P.-P. Pastoret, M. Fukuda, and A. Vanderplasschen
The core 2 {beta}-1,6-N-acetylglucosaminyltransferase-M encoded by bovine herpesvirus 4 is not essential for virus replication despite contributing to post-translational modifications of structural proteins
J. Gen. Virol., February 1, 2004; 85(2): 355 - 367.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Chibber, B. M. Ben-Mahmud, G. E. Mann, J. J. Zhang, and E. M. Kohner
Protein Kinase C {beta}2-Dependent Phosphorylation of Core 2 GlcNAc-T Promotes Leukocyte-Endothelial Cell Adhesion: A Mechanism Underlying Capillary Occlusion in Diabetic Retinopathy
Diabetes, June 1, 2003; 52(6): 1519 - 1527.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
V. R. Falkenberg, K. Alvarez, C. Roman, and N. Fregien
Multiple transcription initiation and alternative splicing in the 5' untranslated region of the core 2 {beta}1-6 N-acetylglucosaminyltransferase I gene
Glycobiology, June 1, 2003; 13(6): 411 - 418.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
I. Brockhausen, M. Lehotay, J.-M. Yang, W. Qin, D. Young, J. Lucien, J. Coles, and H. Paulsen
Glycoprotein biosynthesis in porcine aortic endothelial cells and changes in the apoptotic cell population
Glycobiology, January 1, 2002; 12(1): 33 - 45.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Schwientek, J.-C. Yeh, S. B. Levery, B. Keck, G. Merkx, A. G. van Kessel, M. Fukuda, and H. Clausen
Control of O-Glycan Branch Formation. MOLECULAR CLONING AND CHARACTERIZATION OF A NOVEL THYMUS-ASSOCIATED CORE 2 beta 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE
J. Biol. Chem., April 6, 2000; 275(15): 11106 - 11113.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Schwientek, M. Nomoto, S. B. Levery, G. Merkx, A. G. van Kessel, E. P. Bennett, M. A. Hollingsworth, and H. Clausen
Control of O-Glycan Branch Formation. MOLECULAR CLONING OF HUMAN cDNA ENCODING A NOVEL beta 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE FORMING CORE 2 AND CORE 4
J. Biol. Chem., February 19, 1999; 274(8): 4504 - 4512.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ujita, J. McAuliffe, T. Schwientek, R. Almeida, O. Hindsgaul, H. Clausen, and M. Fukuda
Synthesis of Poly-N-acetyllactosamine in Core 2 Branched O-Glycans. THE REQUIREMENT OF NOVEL beta -1,4-GALACTOSYLTRANSFERASE IV AND beta -1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE
J. Biol. Chem., December 25, 1998; 273(52): 34843 - 34849.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Tsuboi and M. Fukuda
Overexpression of Branched O-Linked Oligosaccharides on T Cell Surface Glycoproteins Impairs Humoral Immune Responses in Transgenic Mice
J. Biol. Chem., November 13, 1998; 273(46): 30680 - 30687.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Sekine, K. Nara, and A. Suzuki
Tissue-specific Regulation of Mouse Core 2 beta -1,6-N-Acetylglucosaminyltransferase
J. Biol. Chem., October 24, 1997; 272(43): 27246 - 27252.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
M F Bierhuizen, M G Mattei, and M Fukuda
Expression of the developmental I antigen by a cloned human cDNA encoding a member of a beta-1,6-N-acetylglucosaminyltransferase gene family.
Genes & Dev., March 1, 1993; 7(3): 468 - 478.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
M. Galvan, S. Tsuboi, M. Fukuda, and L. G. Baum
Expression of a Specific Glycosyltransferase Enzyme Regulates T Cell Death Mediated by Galectin-1
J. Biol. Chem., May 26, 2000; 275(22): 16730 - 16737.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Vanderplasschen, N. Markine-Goriaynoff, P. Lomonte, M. Suzuki, N. Hiraoka, J.-C. Yeh, F. Bureau, L. Willems, E. Thiry, M. Fukuda, et al.
A multipotential beta -1,6-N-acetylglucosaminyl-transferase is encoded by bovine herpesvirus type 4
PNAS, May 23, 2000; 97(11): 5756 - 5761.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.